Neurotrophin signaling in cancer stem cells

Cellular and Molecular Life Sciences

Volumn 73, Issue 9, 2016, Pages 1859-1870

  Chopin, Valérie ^a,b   Lagadec, Chann ^a   Toillon, Robert Alain ^a   Le Bourhis, Xuefen ^a  

^a UNIV LILLE   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

Epithelial mesenchymal transition; P75NTR; Signaling pathways; TrkA; TrkB; Tumor initiating cells

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; NERVE GROWTH FACTOR; NESTIN; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 3 RECEPTOR; NEUROTROPHIN 4; NEUROTROPHIN RECEPTOR P75; PROTEIN KINASE B; PROTEIN TYROSINE KINASE A; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; NERVE GROWTH FACTOR RECEPTOR;

ANGIOGENESIS; CANCER STEM CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SUBPOPULATION; CELL SURVIVAL; ENZYME ACTIVATION; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CYTOLOGY; METABOLISM;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASTIC STEM CELLS; NERVE GROWTH FACTORS; RECEPTORS, NERVE GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84958787545     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-016-2156-7     Document Type: Review

References (129)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A et al (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983-3988. doi: 10.1073/pnas.0530291100
2. Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432:396-401. doi: 10.1038/nature03128
3. Curley MD, Therrien VA, Cummings CL et al (2009) CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells 27:2875-2883. doi: 10.1002/stem.236
4. O'Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106-110. doi: 10.1038/nature05372
5. Schepers AG, Snippert HJ, Stange DE et al (2012) Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 337:730-735. doi: 10.1126/science.1224676
6. Chen J, Li Y, Yu T-SS et al (2012) A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488:522-526. doi: 10.1038/nature11287
7. Driessens G, Beck B, Caauwe A et al (2012) Defining the mode of tumour growth by clonal analysis. Nature 488:527-530. doi: 10.1038/nature11344
8. Eppert K, Takenaka K, Lechman ER et al (2011) Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med 17:1086-1093. doi: 10.1038/nm.2415
9. Liu S, Liu C, Min X et al (2013) Prognostic value of cancer stem cell marker aldehyde dehydrogenase in ovarian cancer: a meta-analysis. PLoS One 8:e81050. doi: 10.1371/journal.pone.0081050
10. Balbous A, Cortes U, Guilloteau K et al (2014) A mesenchymal glioma stem cell profile is related to clinical outcome. Oncogenesis 3:e91. doi: 10.1038/oncsis.2014.5
11. Wicha MS (2012) Migratory gene expression signature predicts poor patient outcome: are cancer stem cells to blame? Breast Cancer Res 14:114. doi: 10.1186/bcr3338
12. Tang DG (2012) Understanding cancer stem cell heterogeneity and plasticity. Cell Res 22:457-472. doi: 10.1038/cr.2012.13
13. Pece S, Tosoni D, Confalonieri S et al (2010) Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 140:62-73. doi: 10.1016/j.cell.2009.12.007
14. Hope KJ, Jin L, Dick JE (2004) Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 5:738-743. doi: 10.1038/ni1080
15. Plaks V, Kong N, Werb Z (2015) The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? Cell Stem Cell 16:225-238. doi: 10.1016/j.stem.2015.02.015
16. Bresnahan PA, Leduc R, Thomas L et al (1990) Human fur gene encodes a yeast KEX2-like endoprotease that cleaves pro-beta-NGF in vivo. J Cell Biol 111:2851-2859
17. Seidah NG, Benjannet S, Pareek S et al (1996) Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases. Biochem J 314(Pt 3):951-960
18. Chao MV (2003) Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 4:299-309. doi: 10.1038/nrn1078
19. Aubert L, Guilbert M, Corbet C et al (2015) NGF-induced TrkA/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib. Oncotarget 6:9807-9819
20. Hecht M, Schulte JH, Eggert A et al (2005) The neurotrophin receptor TrkB cooperates with c-Met in enhancing neuroblastoma invasiveness. Carcinogenesis 26:2105-2115. doi: 10.1093/carcin/bgi192
21. Skeldal S, Matusica D, Nykjaer A, Coulson EJ (2011) Proteolytic processing of the p75 neurotrophin receptor: a prerequisite for signalling?: Neuronal life, growth and death signalling are crucially regulated by intra-membrane proteolysis and trafficking of p75(NTR). BioEssays 33:614-625. doi: 10.1002/bies.201100036
22. Esposito D, Patel P, Stephens RM et al (2001) The cytoplasmic and transmembrane domains of the p75 and Trk A receptors regulate high affinity binding to nerve growth factor. J Biol Chem 276:32687-32695. doi: 10.1074/jbc.M011674200
23. Iacaruso MFF, Galli S, Martí M et al (2011) Structural model for p75(NTR)-TrkA intracellular domain interaction: a combined FRET and bioinformatics study. J Mol Biol 414:681-698. doi: 10.1016/j.jmb.2011.09.022
24. Lu B, Pang PT, Woo NH (2005) The yin and yang of neurotrophin action. Nat Rev Neurosci 6:603-614. doi: 10.1038/nrn1726
25. Dang C, Zhang Y, Ma Q, Shimahara Y (2006) Expression of nerve growth factor receptors is correlated with progression and prognosis of human pancreatic cancer. J Gastroenterol Hepatol 21:850-858. doi: 10.1111/j.1440-1746.2006.04074.x
26. Ma J, Jiang Y, Jiang Y et al (2008) Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer. J Gastroenterol Hepatol 23:1852-1859. doi: 10.1111/j.1440-1746.2008.05579.x
27. Kolokythas A, Cox DP, Dekker N, Schmidt BL (2010) Nerve growth factor and tyrosine kinase A receptor in oral squamous cell carcinoma: is there an association with perineural invasion? J Oral Maxillofac Surg 68:1290-1295. doi: 10.1016/j.joms.2010.01.006
28. Kobayashi K, Ando M, Saito Y et al (2015) Nerve growth factor signals as possible pathogenic biomarkers for perineural invasion in adenoid cystic carcinoma. Otolaryngol Head Neck Surg 153:218-224. doi: 10.1177/0194599815584762
29. Davidson B, Reich R, Lazarovici P et al (2003) Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma. Clin Cancer Res 9:2248-2259
30. Davidson B, Konstantinovsky S, Nielsen S et al (2004) Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression. Clin Cancer Res 10:7335-7346. doi: 10.1158/1078-0432.CCR-04-0183
31. Zhang Y, Dang C, Ma Q, Shimahara Y (2005) Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer. Oncol Rep 14:161-171
32. Adriaenssens E, Vanhecke E, Saule P et al (2008) Nerve growth factor is a potential therapeutic target in breast cancer. Cancer Res 68:346-351. doi: 10.1158/0008-5472.CAN-07-1183
33. Lagadec C, Meignan S, Adriaenssens E et al (2009) TrkA overexpression enhances growth and metastasis of breast cancer cells. Oncogene 28:1960-1970. doi: 10.1038/onc.2009.61
34. Lagadec C, Romon R, Tastet C et al (2010) Ku86 is important for TrkA overexpression-induced breast cancer cell invasion. Proteomics Clin Appl 4:580-590. doi: 10.1002/prca.200900148
35. Romon R, Adriaenssens E, Lagadec C et al (2010) Nerve growth factor promotes breast cancer angiogenesis by activating multiple pathways. Mol Cancer 9:157. doi: 10.1186/1476-4598-9-157
36. Nico B, Mangieri D, Benagiano V et al (2008) Nerve growth factor as an angiogenic factor. Microvasc Res 75:135-141. doi: 10.1016/j.mvr.2007.07.004
37. Nakagawara A, Arima M, Azar CG et al (1992) Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Cancer Res 52:1364-1368
38. Nakagawara A, Arima-Nakagawara M, Scavarda NJ et al (1993) Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328:847-854. doi: 10.1056/NEJM199303253281205
39. Suzuki T, Bogenmann E, Shimada H et al (1993) Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J Natl Cancer Inst 85:377-384
40. Ho R, Minturn JE, Simpson AM et al (2011) The effect of P75 on Trk receptors in neuroblastomas. Cancer Lett 305:76-85. doi: 10.1016/j.canlet.2011.02.029
41. Tacconelli A, Farina AR, Cappabianca L et al (2004) TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma. Cancer Cell 6:347-360. doi: 10.1016/j.ccr.2004.09.011
42. Schramm A, Schowe B, Fielitz K et al (2012) Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome. Br J Cancer 107:1409-1417. doi: 10.1038/bjc.2012.391
43. Barker PA, Lomen-Hoerth C, Gensch EM et al (1993) Tissue-specific alternative splicing generates two isoforms of the trkA receptor. J Biol Chem 268:15150-15157
44. Farina AR, Tacconelli A, Cappabianca L et al (2009) The alternative TrkAIII splice variant targets the centrosome and promotes genetic instability. Mol Cell Biol 29:4812-4830. doi: 10.1128/MCB.00352-09
45. Sasahira T, Ueda N, Yamamoto K et al (2013) Trks are novel oncogenes involved in the induction of neovascularization, tumor progression, and nodal metastasis in oral squamous cell carcinoma. Clin Exp Metastasis 30:165-176. doi: 10.1007/s10585-012-9525-x
46. Sinkevicius KW, Kriegel C, Bellaria KJ et al (2014) Neurotrophin receptor TrkB promotes lung adenocarcinoma metastasis. Proc Natl Acad Sci USA 111:10299-10304. doi: 10.1073/pnas.1404399111
47. Vanhecke E, Adriaenssens E, Verbeke S et al (2011) Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival. Clin Cancer Res 17:1741-1752. doi: 10.1158/1078-0432.CCR-10-1890
48. Okugawa Y, Tanaka K, Inoue Y et al (2013) Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in gastric cancer. Br J Cancer 108:121-130. doi: 10.1038/bjc.2012.499
49. Tanaka K, Okugawa Y, Toiyama Y et al (2014) Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer. PLoS One 9:e96410. doi: 10.1371/journal.pone.0096410
50. Segal RA, Goumnerova LC, Kwon YK et al (1994) Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci USA 91:12867-12871
51. Eggert A, Grotzer MA, Ikegaki N et al (2001) Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms' tumor. J Clin Oncol 19:689-696
52. Sclabas GM, Fujioka S, Schmidt C et al (2005) Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells. Clin Cancer Res 11:440-449
53. Kawamura K, Kawamura N, Okamoto N, Manabe M (2013) Suppression of choriocarcinoma invasion and metastasis following blockade of BDNF/TrkB signaling. Cancer Med 2:849-861. doi: 10.1002/cam4.158
54. Eggert A, Grotzer MA, Ikegaki N et al (2002) Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells. Cancer Res 62:1802-1808
55. Lucarelli E, Kaplan D, Thiele CJ (1997) Activation of trk-A but not trk-B signal transduction pathway inhibits growth of neuroblastoma cells. Eur J Cancer 33:2068-2070
56. Kawamura K, Kawamura N, Okamoto N et al (2013) Suppression of choriocarcinoma invasion and metastasis following blockade of BDNF/TrkB signaling. Cancer Med 2(6):849-861. doi: 10.1002/cam4.158
57. Kermani P, Rafii D, Jin DK et al (2005) Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors. J Clin Invest. 115(3):653-663
58. Jin H, Pan Y, Zhao L et al (2007) p75 neurotrophin receptor suppresses the proliferation of human gastric cancer cells. Neoplasia 9(6):471-478
59. Tabassum A, Khwaja F, Djakiew D (2003) The p75(NTR) tumor suppressor induces caspase-mediated apoptosis in bladder tumor cells. Int J Cancer 105(1):47-52
60. Khwaja F, Tabassum A, Allen J, Djakiew D (2006) The p75(NTR) tumor suppressor induces cell cycle arrest facilitating caspase mediated apoptosis in prostate tumor cells. Biochem Biophys Res Commun 341(4):1184-1192
61. Verbeke S, Meignan S, Lagadec C et al (2010) Overexpression of p75(NTR) increases survival of breast cancer cells through p21(waf1). Cell Signal 22:1864-1873. doi: 10.1016/j.cellsig.2010.07.014
62. Johnston AL, Lun X, Rahn JJ et al (2007) The p75 neurotrophin receptor is a central regulator of glioma invasion. PLoS Biol 5(8):e212
63. Truzzi F, Marconi A, Lotti R et al (2008) Neurotrophins and their receptors stimulate melanoma cell proliferation and migration. J Invest Dermatol 128(8):2031-2040. doi: 10.1038/jid.2008.21
64. Denkins Y, Reiland J, Roy M et al (2004) Brain metastases in melanoma: roles of neurotrophins. Neuro Oncol 6(2):154-165
65. Marchetti D, McQuillan DJ, Spohn WC et al (1996) Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations. Cancer Res 56(12):2856-2863
66. Civenni G, Walter A, Kobert N et al (2011) Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res 71(8):3098-3109. doi: 10.1158/0008-5472.CAN-10-3997
67. Kiyosue T, Kawano S, Matsubara R et al (2013) Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma. Int J Clin Oncol 18(1):154-163. doi: 10.1007/s10147-011-0358-4
68. Lewis Kelso R, Colome-Grimmer MI, Uchida T et al (2006) p75(NGFR) immunostaining for the detection of perineural invasion by cutaneous squamous cell carcinoma. Dermatol Surg 32(2):177-183
69. Tomellini E, Lagadec C, Polakowska R, Le Bourhis X (2014) Role of p75 neurotrophin receptor in stem cell biology: more than just a marker. Cell Mol Life Sci 71(13):2467-2481. doi: 10.1007/s00018-014-1564-9
70. Xiong J, Zhou LI, Lim Y et al (2015) Mature brain-derived neurotrophic factor and its receptor TrkB are upregulated in human glioma tissues. Oncol Lett 10(1):223-227
71. Xiong J, Zhou L, Lim Y et al (2013) Mature BDNF promotes the growth of glioma cells in vitro. Oncol Rep 30(6):2719-2724. doi: 10.3892/or.2013.2746
72. Lawn S, Krishna N, Pisklakova A et al (2015) Neurotrophin signaling via TrkB and TrkC receptors promotes the growth of brain tumor-initiating cells. J Biol Chem 290(6):3814-3824. doi: 10.1074/jbc.M114.599373
73. Wang L, Rahn JJ, Lun X et al (2008) Gamma-secretase represents a therapeutic target for the treatment of invasive glioma mediated by the p75 neurotrophin receptor. PLoS Biol 6(11):e289. doi: 10.1371/journal.pbio.0060289
74. Ahn BY, Saldanha-Gama RF, Rahn JJ et al (2015) Glioma invasion mediated by the p75 neurotrophin receptor (p75NTR/CD271) requires regulated interaction with PDLIM1. Oncogene. doi: 10.1038/onc.2015.199 (Epub ahead of print)
75. Forsyth PA, Krishna N, Lawn S et al (2014) p75 neurotrophin receptor cleavage by α- and γ-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cells. J Biol Chem 289(12):8067-8085. doi: 10.1074/jbc.M113.513762
76. Scala S, Wosikowski K, Giannakakou P et al (1996) Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity. Cancer Res 56(16):3737-3742
77. Jaboin J, Kim CJ, Kaplan DR, Thiele CJ (2002) Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3′-kinase pathway. Cancer Res 62(22):6756-6763
78. Matsumoto K, Wada RK, Yamashiro JM et al (1995) Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res 55(8):1798-1806
79. Li Z, Jaboin J, Dennis PA, Thiele CJ (2005) Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death. Cancer Res 65(6):2070-2075
80. Li Z, Tan F, Thiele CJ (2007) Inactivation of glycogen synthase kinase-3beta contributes to brain-derived neutrophic factor/TrkB-induced resistance to chemotherapy in neuroblastoma cells. Mol Cancer Ther 6(12 Pt 1):3113-3121
81. Yilmaz T, Jiffar T, de la Garza G et al (2010) Theraputic targeting of Trk supresses tumor proliferation and enhances cisplatin activity in HNSCC. Cancer Biol Ther 10(6):644-653. doi: 10.4161/cbt.10.6.12782
82. Kupferman ME, Jiffar T, El-Naggar A et al (2010) TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma. Oncogene 29(14):2047-2059. doi: 10.1038/onc.2009.486
83. Redmer T, Welte Y, Behrens D et al (2014) The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells. PLoS One 9(5):e92596. doi: 10.1371/journal.pone.0092596
84. Ricci A, De Vitis C, Noto A et al (2013) TrkB is responsible for EMT transition in malignant pleural effusions derived cultures from adenocarcinoma of the lung. Cell Cycle 12(11):1696-1703. doi: 10.4161/cc.24759
85. Wang W, Zhao H, Zhang S et al (2009) Patterns of expression and function of the p75(NGFR) protein in pancreatic cancer cells and tumours. Eur J Surg Oncol 35(8):826-832. doi: 10.1016/j.ejso.2008.10.013
86. Davidson B, Reich R, Lazarovici P et al (2004) Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma. Breast Cancer Res Treat 83(2):119-128
87. Descamps S, Toillon RA, Adriaenssens E et al (2001) Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways. J Biol Chem 276(21):17864-17870
88. Tagliabue E, Castiglioni F, Ghirelli C et al (2000) Nerve growth factor cooperates with p185(HER2) in activating growth of human breast carcinoma cells. J Biol Chem 275(8):5388-5394
89. Verbeke S, Tomellini E, Dhamani F et al (2013) Extracellular cleavage of the p75 neurotrophin receptor is implicated in its pro-survival effect in breast cancer cells. FEBS Lett 587(16):2591-2596. doi: 10.1016/j.febslet.2013.06.039
90. Yin B, Ma ZY, Zhou ZW et al (2015) The TrkB+ cancer stem cells contribute to post-chemotherapy recurrence of triple-negative breast cancers in an orthotopic mouse model. Oncogene 34(6):761-770. doi: 10.1038/onc.2014.8
91. Louie E, Chen XF, Coomes A et al (2013) Neurotrophin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasis. Oncogene 32(35):4064-4077. doi: 10.1038/onc.2012.417
92. Fujikawa H, Tanaka K, Toiyama Y et al (2012) High TrkB expression levels are associated with poor prognosis and EMT induction in colorectal cancer cells. J Gastroenterol 47(7):775-784. doi: 10.1007/s00535-012-0532-0
93. Sasahira T, Ueda N, Kurihara M et al (2013) Tropomyosin receptor kinases B and C are tumor progressive and metastatic marker in colorectal carcinoma. Hum Pathol 44(6):1098-1106. doi: 10.1016/j.humpath.2012.09.016
94. Ødegaard E, Staff AC, Abeler VM et al (2007) The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma. Hum Pathol 38(1):140-146
95. Matusica D, Skeldal S, Sykes AM et al (2013) An intracellular domain fragment of the p75 neurotrophin receptor (p75(NTR)) enhances tropomyosin receptor kinase A (TrkA) receptor function. J Biol Chem 288(16):11144-11154. doi: 10.1074/jbc.M112.436469
96. Kommaddi RP, Thomas R, Ceni C et al (2011) Trk-dependent ADAM17 activation facilitates neurotrophin survival signaling. FASEB J 25(6):2061-2070. doi: 10.1096/fj.10-173740
97. Ceni C, Kommaddi RP, Thomas R et al (2010) The p75NTR intracellular domain generated by neurotrophin-induced receptor cleavage potentiates Trk signaling. J Cell Sci 123(Pt 13):2299-2307. doi: 10.1242/jcs.062612
98. Gallia GL, Tyler BM, Hann CL et al (2009) Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells. Mol Cancer Ther 8(2):386-393. doi: 10.1158/1535-7163.MCT-08-0680
99. Eyler CE, Foo WC, LaFiura KM et al (2008) Brain cancer stem cells display preferential sensitivity to Akt inhibition. Stem Cells 26(12):3027-3036. doi: 10.1634/stemcells.2007-1073
100. Reichardt LF (2006) Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 361(1473):1545-1564
101. Bonni A, Brunet A, West AE et al (1999) Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286(5443):1358-1362
102. Xing J, Kornhauser JM, Xia Z et al (1998) Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. Mol Cell Biol 18(4):1946-1955
103. Atwal JK, Singh KK, Tessier-Lavigne M et al (2003) Semaphorin 3F antagonizes neurotrophin-induced phosphatidylinositol 3-kinase and mitogen-activated protein kinase kinase signaling: a mechanism for growth cone collapse. J Neurosci 23(20):7602-7609
104. Ruggeri P, Farina AR, Di Ianni N et al (2014) The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype. PLoS One 9(4):e94568. doi: 10.1371/journal.pone.0094568 (eCollection 2014)
105. Murillo-Sauca O, Chung MK, Shin JH et al (2014) CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma. Oncotarget 5(16):6854-6866
106. Tomellini E, Touil Y, Lagadec C et al (2015) Nerve growth factor and proNGF simultaneously promote symmetric self-renewal, quiescence, and epithelial to mesenchymal transition to enlarge the breast cancer stem cell compartment. Stem Cells 33(2):342-353. doi: 10.1002/stem.1849
107. Morrison SJ, Kimble J (2006) Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 441(7097):1068-1074
108. Nykjaer A, Lee R, Teng KK et al (2004) Sortilin is essential for proNGF-induced neuronal cell death. Nature 427(6977):843-848
109. Vaegter CB, Jansen P, Fjorback AW et al (2011) Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling. Nat Neurosci 14(1):54-61. doi: 10.1038/nn.2689
110. Demont Y, Corbet C, Page A et al (2012) Pro-nerve growth factor induces autocrine stimulation of breast cancer cell invasion through tropomyosin-related kinase A (TrkA) and sortilin protein. J Biol Chem 287(3):1923-1931. doi: 10.1074/jbc.M110.211714
111. Yan Y, Zuo X, Wei D (2015) Concise review: emerging role of CD44 in cancer stem cells: a promising biomarker and therapeutic target. Stem Cells Transl Med 4(9):1033-1043. doi: 10.5966/sctm.2015-0048
112. Chanmee T, Ontong P, Kimata K, Itano N (2015) Key roles of hyaluronan and its CD44 receptor in the stemness and survival of cancer stem cells. Front Oncol 5:180. doi: 10.3389/fonc.2015.00180.eCollection
113. Zöller M (2011) CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 11(4):254-267. doi: 10.1038/nrc3023
114. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663-676
115. Park IH, Zhao R, West JA et al (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451(7175):141-146
116. Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15(3):178-196. doi: 10.1038/nrm3758
117. Chaffer CL, Marjanovic ND, Lee T et al (2013) Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 154(1):61-74. doi: 10.1016/j.cell.2013.06.005
118. Herreros-Villanueva M, Zhang JS, Koenig A et al (2013) SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells. Oncogenesis 2:e61. doi: 10.1038/oncsis.2013.23
119. Guo W, Keckesova Z, Donaher JL et al (2012) Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 148(5):1015-1028. doi: 10.1016/j.cell.2012.02.008
120. Ye X, Tam WL, Shibue T et al (2015) Distinct EMT programs control normal mammary stem cells and tumour-initiating cells. Nature 525(7568):256-260. doi: 10.1038/nature14897
121. Götz R, Sendtner M (2014) Cooperation of tyrosine kinase receptor TrkB and epidermal growth factor receptor signaling enhances migration and dispersal of lung tumor cells. PLoS One 9(6):e100944. doi: 10.1371/journal.pone.0100944.eCollection
122. Bao W, Wang HH, Tian FJ et al (2013) A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells. Mol Cancer 12:155. doi: 10.1186/1476-4598-12-155
123. Bao W, Qiu H, Yang T et al (2013) Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma. PLoS One 8(7):e70616. doi: 10.1371/journal.pone.0070616
124. Howe EN, Cochrane DR, Richer JK (2011) Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res 13(2):R45. doi: 10.1186/bcr2867
125. Smit MA, Geiger TR, Song JY et al (2009) A twist-snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol Cell Biol 29(13):3722-3737. doi: 10.1128/MCB.01164-08
126. Smit MA, Peeper DS (2011) Zeb1 is required for TrkB-induced epithelial-mesenchymal transition, anoikis resistance and metastasis. Oncogene 30(35):3735-3744. doi: 10.1038/onc.2011.96
127. Ricci A, Mariotta S, Pompili E et al (2010) Neurotrophin system activation in pleural effusions. Growth Factors 28(4):221-231. doi: 10.3109/08977191003677402
128. Basak SK, Veena MS, Oh S et al (2009) The malignant pleural effusion as a model to investigate intratumoral heterogeneity in lung cancer. PLoS One 4(6):e5884. doi: 10.1371/journal.pone.0005884
129. Mancini R, Giarnieri E, De Vitis C et al (2011) Spheres derived from lung adenocarcinoma pleural effusions: molecular characterization and tumor engraftment. PLoS One 6(7):e21320. doi: 10.1371/journal.pone.0021320